Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson's Disease Patients with Cognitive Deficits: A Meta-Analysis

OBJECTIVES: To evaluate the effects of atomoxetine on complex attention and other neurocognitive domains in idiopathic Parkinson's disease (PD). METHODS: Interventional trials reporting changes in complex attention and other neurocognitive functions (Diagnostic and Statistical Manual of Mental...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Abhinaba, Das, Saibal, Behera, Sapan Kumar, Ramakrishnan, Kirubakaran, Selvarajan, Sandhiya, Kandasamy, Preeti, Nair, N Sreekumaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049416/
https://www.ncbi.nlm.nih.gov/pubmed/32211146
http://dx.doi.org/10.1155/2020/4853590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049416/
https://www.ncbi.nlm.nih.gov/pubmed/32211146
http://dx.doi.org/10.1155/2020/4853590

Ejemplares similares